Shareholder centre

Reports & results

ESM Rule 26 

Investor Relations contact

Media & analyst coverage

Corporate Governance & Constitutional documents


PrecisionBiotics develops best in class, clinically supported healthcare and nutritional products for consumers and partners worldwide.

There is growing acceptance of the microbiome’s importance by healthcare professionals, aided by the quality of clinical evidence and trials supporting individual strains. PrecisionBiotics and its partners have been key to driving recognition of the vital role that specific strains have on human health.


Reports & Results

  • Annual Report 2017

  • Presentation NPD Zenflore

  • Probiotics Market Review

  • Presentation IMS Q4 2017

Calender of events


Corporate Governance

The management team has a proven track record and wealth of experience in research and product commercialisation and are supported by a Board of Directors that combine depth of scientific oversight with commercial and venture experience.


Media coverage

Sunday Business Post, November 2017

Sunday Business Post, November 2017

Irish Times, February 2014

Irish Times, February 2014


Media and Investor Relations contact:

Colm O Sullivan, Head of Communciations: ++353 21 429 9104.